Lhermitte–Duclos disease

From WikiMD's Food, Medicine & Wellness Encyclopedia

(Redirected from Lhermitte-Duclos disease)

Dysplastic cerebellar gangliocytoma

Lhermitte–Duclos disease (LDD), also known as dysplastic gangliocytoma of the cerebellum, is a rare, slow-growing brain tumor that typically affects the cerebellum. It is characterized by an overgrowth of the ganglion cells in the cerebellar cortex, leading to a distinctive appearance on magnetic resonance imaging (MRI) scans.

Presentation[edit | edit source]

Patients with Lhermitte–Duclos disease often present with symptoms related to increased intracranial pressure due to the mass effect of the tumor. Common symptoms include headache, nausea, vomiting, ataxia, and visual disturbances. In some cases, patients may also experience seizures.

Pathophysiology[edit | edit source]

The exact cause of Lhermitte–Duclos disease is not well understood. However, it is believed to be associated with mutations in the PTEN gene, which is also implicated in Cowden syndrome. The overgrowth of ganglion cells leads to the characteristic thickening of the cerebellar folia, which can be observed on MRI as a "tiger-striped" pattern.

Diagnosis[edit | edit source]

Diagnosis of Lhermitte–Duclos disease is primarily based on imaging studies. MRI is the preferred modality, as it can reveal the distinctive striated appearance of the cerebellar cortex. Computed tomography (CT) scans may also be used, but they are less specific. A definitive diagnosis may require a biopsy to confirm the presence of dysplastic ganglion cells.

Treatment[edit | edit source]

Treatment options for Lhermitte–Duclos disease vary depending on the size and location of the tumor, as well as the severity of symptoms. Surgical resection is often the treatment of choice, especially in cases where the tumor is causing significant mass effect or symptoms. In some cases, radiotherapy or chemotherapy may be considered, although their effectiveness is less well established.

Prognosis[edit | edit source]

The prognosis for patients with Lhermitte–Duclos disease is generally favorable, especially if the tumor can be surgically resected. However, the risk of recurrence exists, and long-term follow-up with regular imaging studies is recommended.

Related Conditions[edit | edit source]

Lhermitte–Duclos disease is often associated with Cowden syndrome, a genetic disorder characterized by multiple noncancerous, tumor-like growths called hamartomas. Patients with Cowden syndrome have an increased risk of developing various types of cancer, including breast cancer, thyroid cancer, and endometrial cancer.

See Also[edit | edit source]

References[edit | edit source]

External Links[edit | edit source]


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD